Literature DB >> 20602020

Validation of a rapid stool antigen test for diagnosis of Helicobacter pylori infection.

Joyce Matie Kinoshita da Silva1, Cibele Aparecida Villares, Maria do Socorro Monteiro, Carlos Colaúto, Anibal Ferreira dos Santos, Rejane Mattar.   

Abstract

The aim of this study was to validate the rapid lateral flow Helicobacter pylori stool antigen test (One step H. pylori antigen test, ACON laboratories, San Diego, USA; Prime diagnostics, São Paulo), using 13C-Urea Breath Test as the gold standard for H. pylori infection diagnosis. A total of 98 consecutive patients, asymptomatic or dyspeptic, entered the study. Sixty-nine were women, with a mean age of 45.76 +/- 14.59 years (14 to 79 years). In the H. pylori-positive group, the rapid stool antigen test detected H. pylori antigen in 44 of the 50 positive patients (sensitivity 88%; 95% CI: 75.7-95.5%), and six false-negative; and in the H. pylori-negative group 42 presented negative results (specificity 87.5%; 95% CI: 74.7-95.3%), and six false-positive, showing a substantial agreement (Kappa Index = 0.75; p < 0.0001; 95% CI: 0.6-0.9). Forty four of fifty patients that had positive stool antigen were H. pylori-positive, the PPV of the stool antigen test was 88% (95% CI: 75.7-95.5%), and 42 patients with negative stool antigen test were H. pylori-negative, the NPV of the stool antigen test was 87.5% (95% CI: 74.7-95.3%). We conclude that the lateral flow stool antigen test can be used as an alternative to breath test for H. pylori infection diagnosis especially in developing countries.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20602020     DOI: 10.1590/s0036-46652010000300002

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  7 in total

1.  Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial.

Authors:  Jaime Natan Eisig; Tomás Navarro-Rodriguez; Ana Cristina Sá Teixeira; Fernando Marcuz Silva; Rejane Mattar; Decio Chinzon; Christiane Haro; Márcio Augusto Diniz; Joaquim Prado Moraes-Filho; Ronnie Fass; Ricardo Correa Barbuti
Journal:  Gastroenterol Res Pract       Date:  2015-05-04       Impact factor: 2.260

2.  Efficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers.

Authors:  Fernando Marcuz Silva; Elaine Cristina Silveira de Queiroz; Tomás Navarro-Rodriguez; Ricardo Correa Barbuti; Rejane Mattar; Kiyoshi Iriya; Jin Hwa Lee; Jaime Natan Eisig
Journal:  Clinics (Sao Paulo)       Date:  2015-05-01       Impact factor: 2.365

3.  Evaluation of antibody immunochromatography testing for diagnosis of current Helicobacter pylori infection.

Authors:  Jamil M A S Obaid; Ayoob N N Ayoon; Omar N M Almurisy; Sammer M S Alshuaibi; Nashwan N Alkhawlani
Journal:  Pract Lab Med       Date:  2021-07-24

4.  Evaluation of the diagnostic performance and the utility of Helicobacter pylori stool antigen lateral immunochromatography assay.

Authors:  Shaymaa Abdelmalek; Wafy Hamed; Neven Nagy; Karim Shokry; Hisham Abdelrahman
Journal:  Heliyon       Date:  2022-03-25

Review 5.  Non-invasive diagnostic tests for Helicobacter pylori infection.

Authors:  Lawrence Mj Best; Yemisi Takwoingi; Sulman Siddique; Abiram Selladurai; Akash Gandhi; Benjamin Low; Mohammad Yaghoobi; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

6.  Investigation of Helicobacter pylori antigen in stool samples of patients with upper gastrointestinal complaints.

Authors:  Zeki Calik; Murat Karamese; Osman Acar; Selina Aksak Karamese; Yalcin Dicle; Fatih Albayrak; Serpil Can; Bulent Guvendi; Alpgiray Turgut; Mustafa Cicek; Halil Yazgi
Journal:  Braz J Microbiol       Date:  2016-01-27       Impact factor: 2.476

7.  Stool antigen detection versus 13C-urea breath test for non-invasive diagnosis of pediatric Helicobacter pylori infection in a limited resource setting.

Authors:  Mortada El-Shabrawi; Nabil Abd El-Aziz; Tarek Zakaria El-Adly; Fetouh Hassanin; Ayman Eskander; Maha Abou-Zekri; Hala Mansour; Safa Meshaal
Journal:  Arch Med Sci       Date:  2016-07-01       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.